日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

MTAP Loss Is Frequent in Oncogene-Driven NSCLC and May Confer Sensitivity to Combined PRMT5 Inhibitors and Targeted Therapies

MTAP缺失在癌基因驱动的非小细胞肺癌中很常见,并可能使肿瘤对PRMT5抑制剂和靶向治疗联合治疗敏感。

Aldea, M; Lenahan, S; Locquet, M-A; Liao, L; Gasparro, M; Gokhale, P C; Ghigna, M-R; Ionescu, D N; Odintsov, I; Ngo, K; Wang, X; Aziz, S; Pecci, F; Garbo, E; Ivanova, E; Nakazawa, S; Kulesza, J; Tsai, J A; Zullo, L; Lee, J; Zielinska, M; Simon, S; Han, D; Marinello, A; Li, G; Rossato de Almeida, G; Huang, J; Paoloni, F; Gariazzo, E; Santo, V; Remon, J; Marks, J A; LoPiccolo, J; Florez, N; Nishino, M; Ricciuti, B; Luo, J; Barbie, D A; Planchard, D; Rotow, J K; Barlesi, F; Graf, R P; Feng, W W; Besse, B; Paweletz, C; Sholl, L; Shaw, A T; Jänne, P A

Global advances and future directions in lung cancer care: expert consensus and strategic priorities

全球肺癌治疗进展及未来方向:专家共识和战略重点

Meyer, M-L; Peters, S; Jänne, P A; Mok, T S; Bunn, P A; Abdel Karim, N; Altorki, N K; Arrieta, O; Bar, J; Cappuzzo, F; Carbone, D; Dacic, S; Diehn, M; Dziadziuszko, R; Felip, E; Flores, R; Florez, N; Forde, P M; Gainor, J F; Gray, J E; Gros, L; Halmos, B; Henschke, C I; Herbst, R; Heymach, J V; Kelly, K; Kris, M G; Leighl, N B; Mathias, C; Marron, T U; Mulshine, J L; Naidoo, J; Osarogiagbon, R; Passaro, A; Peled, N; Planchard, D; Politi, K; Popat, S; Pyenson, B; Reckamp, K L; Ren, S H; Riely, G J; Rolfo, C; Rudin, C M; Sen, T; Shields, M D; Singh, H; Skoulidis, F; Solomon, B J; Stahel, R; Stiles, B M; Syrigos, K; Yang, J C-H; Yang, P-C; Wolf, A; Wozniak, A J; Waqar, S N; Wakelee, H; Hirsch, F R

Efficacy of Neratinib-Based Therapy in ERBB2-Mutant Lung Adenocarcinomas: Findings From 2 International Phase 2 Studies

奈拉替尼治疗ERBB2突变型肺腺癌的疗效:两项国际II期研究的结果

Li, Bob T; Gandhi, Leena; Ravichandran, Vignesh; Besse, Benjamin; Mazières, Julien; Shapiro, Geoffrey I; Boni, Valentina; Waqar, Saiama N; Park, Haeseong; Quinn, David I; Martinez, Alejandro; Stemmer, Salomon M; Cortot, Alexis B; Barlesi, Fabrice; Quoix, Elisabeth; Burkard, Mark E; Selcuklu, S Duygu; Hunt, Casey; Donoghue, Mark T A; Kris, Mark G; Bebchuk, Judith; Eli, Lisa D; McCulloch, Leanne; Solit, David B; Jänne, Pasi A

Lung adenocarcinomas with mucinous histology: clinical, genomic, and immune microenvironment characterization and outcomes to immunotherapy-based treatments and KRAS(G12C) inhibitors

具有黏液性组织学特征的肺腺癌:临床、基因组和免疫微环境特征以及基于免疫疗法和KRAS(G12C)抑制剂的治疗结果

Di Federico, A; Hong, L; Elkrief, A; Thummalapalli, R; Cooper, A J; Ricciuti, B; Digumarthy, S; Alessi, J V; Gogia, P; Pecci, F; Makarem, M; Gandhi, M M; Garbo, E; Saini, A; De Giglio, A; Favorito, V; Scalera, S; Cipriani, L; Marinelli, D; Haradon, D; Nguyen, T; Haradon, J; Voligny, E; Vaz, V; Gelsomino, F; Sperandi, F; Melotti, B; Ladanyi, M; Zhang, J; Gibbons, D L; Heymach, J V; Nishino, M; Lindsay, J; Rodig, S J; Pfaff, K; Sholl, L M; Wang, X; Johnson, B E; Jänne, P A; Rekhtman, N; Maugeri-Saccà, M; Heist, R S; Ardizzoni, A; Awad, M M; Arbour, K C; Schoenfeld, A J; Vokes, N I; Luo, J

Transferrin receptor targeting chimeras for membrane protein degradation

转铁蛋白受体靶向嵌合体用于膜蛋白降解

Dingpeng Zhang,Jhoely Duque-Jimenez,Francesco Facchinetti ,Garyk Brixi,Kaitlin Rhee,William W Feng ,Pasi A Jänne ,Xin Zhou

Transferrin receptor targeting chimeras for membrane protein degradation

转铁蛋白受体靶向嵌合体用于膜蛋白降解

Dingpeng Zhang ,Jhoely Duque-Jimenez ,Francesco Facchinetti ,Garyk Brixi ,Kaitlin Rhee ,William W Feng ,Pasi A Jänne ,Xin Zhou

Author Correction: CTLA4 blockade abrogates KEAP1/STK11-related resistance to PD-(L)1 inhibitors

作者更正:CTLA4阻断可消除KEAP1/STK11相关的PD-(L)1抑制剂耐药性

Skoulidis, Ferdinandos; Araujo, Haniel A; Do, Minh Truong; Qian, Yu; Sun, Xin; Cobo, Ana Galan; Le, John T; Montesion, Meagan; Palmer, Rachael; Jahchan, Nadine; Juan, Joseph M; Min, Chengyin; Yu, Yi; Pan, Xuewen; Arbour, Kathryn C; Vokes, Natalie; Schmidt, Stephanie T; Molkentine, David; Owen, Dwight H; Memmott, Regan; Patil, Pradnya D; Marmarelis, Melina E; Awad, Mark M; Murray, Joseph C; Hellyer, Jessica A; Gainor, Justin F; Dimou, Anastasios; Bestvina, Christine M; Shu, Catherine A; Riess, Jonathan W; Blakely, Collin M; Pecot, Chad V; Mezquita, Laura; Tabbó, Fabrizio; Scheffler, Matthias; Digumarthy, Subba; Mooradian, Meghan J; Sacher, Adrian G; Lau, Sally C M; Saltos, Andreas N; Rotow, Julia; Johnson, Rocio Perez; Liu, Corinne; Stewart, Tyler; Goldberg, Sarah B; Killam, Jonathan; Walther, Zenta; Schalper, Kurt; Davies, Kurtis D; Woodcock, Mark G; Anagnostou, Valsamo; Marrone, Kristen A; Forde, Patrick M; Ricciuti, Biagio; Venkatraman, Deepti; Van Allen, Eliezer M; Cummings, Amy L; Goldman, Jonathan W; Shaish, Hiram; Kier, Melanie; Katz, Sharyn; Aggarwal, Charu; Ni, Ying; Azok, Joseph T; Segal, Jeremy; Ritterhouse, Lauren; Neal, Joel W; Lacroix, Ludovic; Elamin, Yasir Y; Negrao, Marcelo V; Le, Xiuning; Lam, Vincent K; Lewis, Whitney E; Kemp, Haley N; Carter, Brett; Roth, Jack A; Swisher, Stephen; Lee, Richard; Zhou, Teng; Poteete, Alissa; Kong, Yifan; Takehara, Tomohiro; Paula, Alvaro Guimaraes; Parra Cuentas, Edwin R; Behrens, Carmen; Wistuba, Ignacio I; Zhang, Jianjun; Blumenschein, George R; Gay, Carl; Byers, Lauren A; Gibbons, Don L; Tsao, Anne; Lee, J Jack; Bivona, Trever G; Camidge, D Ross; Gray, Jhannelle E; Leighl, Natasha B; Levy, Benjamin; Brahmer, Julie R; Garassino, Marina C; Gandara, David R; Garon, Edward B; Rizvi, Naiyer A; Scagliotti, Giorgio Vittorio; Wolf, Jürgen; Planchard, David; Besse, Benjamin; Herbst, Roy S; Wakelee, Heather A; Pennell, Nathan A; Shaw, Alice T; Jänne, Pasi A; Carbone, David P; Hellmann, Matthew D; Rudin, Charles M; Albacker, Lee; Mann, Helen; Zhu, Zhou; Lai, Zhongwu; Stewart, Ross; Peters, Solange; Johnson, Melissa L; Wong, Kwok K; Huang, Alan; Winslow, Monte M; Rosen, Michael J; Winters, Ian P; Papadimitrakopoulou, Vassiliki A; Cascone, Tina; Jewsbury, Philip; Heymach, John V

First-Line Mobocertinib Versus Platinum-Based Chemotherapy in Patients With EGFR Exon 20 Insertion-Positive Metastatic Non-Small Cell Lung Cancer in the Phase III EXCLAIM-2 Trial

在III期EXCLAIM-2试验中,一线Mobocertinib与铂类化疗在EGFR 20号外显子插入阳性转移性非小细胞肺癌患者中的疗效比较

Jänne, Pasi A; Wang, Bin-Chao; Cho, Byoung Chul; Zhao, Jun; Li, Juan; Hochmair, Maximilian; Peters, Solange; Besse, Benjamin; Pavlakis, Nick; Neal, Joel W; Kato, Terufumi; Wu, Yi-Long; Nguyen, Danny; Lin, Junjing; Lin, Jianchang; Vranceanu, Florin; Szumski, Annette; Lin, Huamao M; Fram, Robert J; Mok, Tony S K

Eradicating Drug-tolerant Persister Cells in EGFR-Mutated Non-Small Cell Lung Cancer by Targeting TROP2 with CAR-T Cellular Therapy

利用CAR-T细胞疗法靶向TROP2,根除EGFR突变型非小细胞肺癌中的耐药性持续细胞

Simon Baldacci ,Elliott J Brea ,Francesco Facchinetti ,Zhaorong Li ,Kenneth Ngo ,Soumya Malhotra ,Matthew A Booker ,Michael Yevgeniy Tolstorukov ,Sachiv Chakravarti ,Conor Hinchey ,Navin R Mahadevan ,Filippo Lococo ,Simona D'Agnelli ,Letizia Gnetti ,Nicoletta Campanini ,Alessandro Leonetti ,William W Feng ,Jeanelle A Tsai ,Antja-Voy Hartley ,Marie-Anaïs Locquet ,Ludovic Fournel ,Marco Alifano ,Audrey Mansuet-Lupo ,Aisha Saldanha ,William Haller ,Lauren M Zasadil ,Magdalena Zielinska ,Karen Bui ,Bishma Tuladhar ,Patrick Hall Lizotte ,Elena V Ivanova ,Lecia V Sequist ,Prafulla C Gokhale ,Cloud P Paweletz ,Eric L Smith ,Pasi A Jänne ,David A Barbie

Expression of Membrane Targets for Therapeutics in RET-Positive Non-Small Cell Lung Cancer

RET阳性非小细胞肺癌中膜靶点的表达及其在治疗中的作用

Marinello, Arianna; Ghigna, Maria Rosa; Rotow, Julia K; Adeyelu, Tolulope; Metro, Giulio; Brandão, Mariana; Guisier, Florian; Monnet, Isabelle; Gaultier de Saint Basile, Hortense; Genova, Carlo; Raimbourg, Judith; Terrisse, Safae; Godefroy, Karine; Toschi, Luca; Mandarano, Martina; Doubre, Hélène; Russo, Alessandro; Valent, Alexander; Naqash, Abdul Rafeh; Aijaz, Ayesha; Gazzah, Anas; Remon, Jordi; Vanderwalde, Ari; Elliott, Andrew; Halmos, Balazs; Barlesi, Fabrice; Planchard, David; Jänne, Pasi A; Besse, Benjamin; Aldea, Mihaela